Pregled bibliografske jedinice broj: 1110484
The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus
The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus // Informatics in Medicine Unlocked, 23 (2021), 100529, 7 doi:10.1016/j.imu.2021.100529 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1110484 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The screening and evaluation of potential clinically significant HIV drug
combinations against the SARS-CoV-2 virus
(The screening and evaluation of potential
clinically significant HIV drug combinations
against the SARS-CoV-2 virus)
Autori
Tomić, Draško ; Davidović, Davor ; Szasz, Attila Marcel ; Rezeli, Melinda ; Pirkić, Boris ; Petrik, Jozsef ; Bačić Vrca, Vesna ; Janđel, Vladimir ; Lipić, Tomislav ; Skala, Karolj ; Mesarić, Josip ; Milković Periša, Marija ; Šojat, Zorislav ; Medved Rogina, Branka
Izvornik
Informatics in Medicine Unlocked (2352-9148) 23
(2021);
100529, 7
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
SARS-CoV-2 spike glycoprotein ; HIV cocktail therapy ; Inhibition efficiency ; Virtual drug screening ; Antiviral drugs ; COVID-19
Sažetak
Spike glycoprotein is essential for the reproduction of the SARS-CoV-2 virus, and its inhibition using already approved antiviral drugs may open new avenues for the treatment of patients with the COVID-19 disease. Because of that, we analyzed the inhibition of SARS-CoV-2 spike glycoprotein with FDA-approved antiviral drugs and their double and triple combinations. We used the Vini in silico model of cancer to perform this virtual drug screening, showing HIV drugs to be the most effective. Besides, the combination of cobicistat-abacavir-rilpivirine HIV drugs demonstrated the highest in silico efficacy of inhibiting SARS-CoV-2 spike glycoprotein. Therefore, a clinical trial of cobicistat- abacavir-rilpivirine on a limited number of COVID- 19 patients in moderately severe and severe conditions is warranted.
Izvorni jezik
Engleski
Znanstvena područja
Računarstvo, Interdisciplinarne tehničke znanosti, Biotehnologija
POVEZANOST RADA
Projekti:
--KK.01.1.1.01.009 - Napredne metode i tehnologije u znanosti o podatcima i kooperativnim sustavima (DATACROSS) (Šmuc, Tomislav; Lončarić, Sven; Petrović, Ivan; Jokić, Andrej; Palunko, Ivana) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Fakultet elektrotehnike i računarstva, Zagreb,
Veterinarski fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb
Profili:
Branka Medved-Rogina
(autor)
Zorislav Šojat
(autor)
Tomislav Lipić
(autor)
Boris Pirkić
(autor)
Draško Tomić
(autor)
Karolj Skala
(autor)
Marija Milković Periša
(autor)
Davor Davidović
(autor)
Vesna Bačić Vrca
(autor)
Jozsef Petrik
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus